Ditchcarbon
  • Contact
  1. Organizations
  2. Pear Therapeutics, Inc.
Public Profile
Computer Services
US
updated 19 days ago

Pear Therapeutics, Inc.

Company website

Pear Therapeutics, Inc., a pioneering leader in the digital therapeutics industry, is headquartered in the United States. Founded in 2013, the company has made significant strides in developing prescription digital therapeutics designed to treat various mental health and substance use disorders. With a focus on evidence-based solutions, Pear Therapeutics offers unique products such as reSET and reSET-O, which integrate seamlessly with traditional therapies to enhance patient outcomes. These innovative offerings set the company apart in a rapidly evolving market, positioning it as a key player in the intersection of technology and healthcare. Recognised for its commitment to advancing therapeutic options, Pear Therapeutics continues to shape the future of treatment through its cutting-edge digital solutions, addressing critical needs in patient care.

DitchCarbon Score

How does Pear Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Pear Therapeutics, Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.

32%

Let us know if this data was useful to you

Pear Therapeutics, Inc.'s reported carbon emissions

Pear Therapeutics, Inc., headquartered in the US, currently does not have publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, Pear Therapeutics has not cascaded any emissions data from a parent or related organisation, nor does it appear to have established any industry-standard climate initiatives such as Science Based Targets (SBTi) or commitments to renewable energy (RE100). In the context of the healthcare and technology sectors, it is increasingly important for companies to develop and disclose their climate strategies to align with global sustainability goals. However, without specific emissions data or commitments, it is challenging to assess Pear Therapeutics' current environmental impact or future climate initiatives.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Pear Therapeutics, Inc.'s primary industry is Computer and related services (72), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Pear Therapeutics, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Pear Therapeutics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Otsuka Pharmaceutical Co., Ltd.

JP
•
Pharmaceutical Preparation Manufacturing
Updated 25 days ago

Sana GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated about 3 hours ago

Lundbeck

DK
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 20 hours ago

Sumitomo Pharma America, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 25 days ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251009.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy